[ad_1] A new study found that Eisai and Biogen’s experimental Alzheimer’s drug moderately reduced cognitive…
Tag:
Biogen Inc.
-
-
[ad_1] Eisai 4523, +1.23% plans to share additional data about the Alzheimer’s disease treatment it’s…
-
STOCK MARKET
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
by userby user[ad_1] Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker…
-
[ad_1] Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug significantly slowed progression of…
-
[ad_1] U.S. stock indexes are trading higher Wednesday, as investors await more quarterly earnings, with…
-
STOCK MARKET
Drug companies are making an accounting change after the SEC cracked down on Biogen
by userby user[ad_1] Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change…
-
[ad_1] Biogen Inc.’s BIIB, +1.23% decision to let go of its CEO and scrap commercial…
- 1
- 2